To include your compound in the COVID-19 Resource Center, submit it here.

Cambridge Antibody Technology plc, Dyax deal

The companies extended their January deal under which CAT granted DYAX a

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE